About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure
By
Piedmont Heart Institute Napa Valley Cardiology Conference
FEATURING
Thomas Deering
November 15, 2019
1 Comment
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Scottsdale Interventional Forum 2021
Scottsdale Interventional Forum 2021 (Hybrid)
Wed, Mar 10, 2021
25:21
Congenital and Structural Interventions
LAA Closure for Atrial Fibrillation using Occlusion Device
Feat.
H. Sievert
14:39
Lankenau
Management of AF patients with ACS
Feat.
P. Kowey,
D. Ice
19:47
Complex Coronary Cases Symposium 2019
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Trip…
Feat.
U. Baber
16:37
Cardiopulmonary Research Science and Technology Institute
Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation
Feat.
G. Stone
25:22
Scottsdale Interventional Forum 2020 Virtual
Why Is the Left Atrial Appendage Occlusion Underutilized?
Feat.
J. Lasala
20:30
Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach
Transcatheter LAA Closure for Stroke Prevention: Current Data and Future D…
Feat.
M. Price
13:21
The North American Thrombosis Forum (NATF)
Novel Trials and Guideline Updates from the 2020 ESC Congress: When to Use…
Feat.
C. Cruff
12:55
Cardiology Fiesta 2018
Heart Failure and Atrial Fibrillation – What Is the Right Approach for You…
Feat.
J. Pillarisetti
15:52
ARCH Advanced Revascularization Symposium
LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy
Feat.
S. Yakubov
30:04
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias
Outpatient Management of Atrial Fibrillation
Feat.
N. Olson
19:28
Northwestern Medicine: 7th Annual Cardiovascular Update
Re-Visiting the Natural History of AF: Who is at Risk of Stroke and What a…
Feat.
R. Passman
21:41
Cardiology Fiesta 2018
Results from the CABANA Trial: What Does it Mean
Feat.
D. Packer
20:15
Cardiology Fiesta 2017
The Guidelines: Current Recommendations for TAVR, Left Atrial Appendage Oc…
Feat.
S. Bailey
14:25
California Heart Rhythm Symposium
Therapies for Atrial Fibrillation in the Next Decade
Feat.
H. Calkins
19:11
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Rationale and Practical Aspects for using NOAC’s to Treat Afib and VTE
Feat.
D. Blanchard
19:58
George Davis
Anticoagulant Reversal Agents
17:08
Jonathan Piccini
Which Direct Acting Oral Anticoagulant for my Patient with Chronic Kidney …
32:34
Cardiovascular Disease Management: A Case-Based Approach 2018
Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Pra…
Feat.
J. Bunch
23:00
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
What’s the Best Way to Manage Patients with Atrial Fibrillation?
Feat.
J. Hsu
13:43
American Heart & Vascular Institute
Review of Oral Anticoagulants for Atrial Fibrillation: What Are the Indica…
Feat.
V. Le